Foghorn Therapeutics Inc. Fair Value Adjustment of Warrants
Foghorn Therapeutics Inc. (FHTX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-08-09
- Foghorn Therapeutics Inc. fair value adjustment of warrants for the quarter ending 2021-12-31 was $0.00.
- Foghorn Therapeutics Inc. fair value adjustment of warrants for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. fair value adjustment of warrants for the quarter ending 2021-06-30 was $0.00.
- Foghorn Therapeutics Inc. fair value adjustment of warrants for the quarter ending 2021-03-31 was $0.00.
- Foghorn Therapeutics Inc. fair value adjustment of warrants for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Foghorn Therapeutics Inc. fair value adjustment of warrants for fiscal 2020 was $69.00K.
- Foghorn Therapeutics Inc. fair value adjustment of warrants for fiscal 2019 was -$1.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $0.00 derived: sum of 2 quarters · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | $0.00 10-K/A · filed 2022-08-09 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-10 | $0.00 10-Q · filed 2021-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-08-09 | $70.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-09 | $70.00K derived: sum of 3 quarters · filed 2022-08-09 | $70.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $70.00K derived: sum of 2 quarters · filed 2022-08-09 | $70.00K derived: sum of 3 quarters · filed 2022-08-09 | $69.00K 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $70.00K 10-Q · filed 2021-11-09 | $70.00K derived: sum of 2 quarters · filed 2021-11-09 | $69.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-10 | -$1.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$1.00K 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | -$1.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |